| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 32 | 2026 | 58 | 10.270 |
Why?
|
| Bariatric Surgery | 27 | 2026 | 44 | 8.670 |
Why?
|
| Laparoscopy | 16 | 2026 | 156 | 4.600 |
Why?
|
| Gastrectomy | 13 | 2025 | 21 | 3.880 |
Why?
|
| Postoperative Complications | 24 | 2026 | 634 | 3.740 |
Why?
|
| Gastric Bypass | 10 | 2025 | 19 | 3.260 |
Why?
|
| Patient Discharge | 5 | 2025 | 109 | 2.060 |
Why?
|
| Middle Aged | 51 | 2026 | 7416 | 1.980 |
Why?
|
| Patient Readmission | 7 | 2026 | 108 | 1.770 |
Why?
|
| Male | 60 | 2026 | 13934 | 1.760 |
Why?
|
| Obesity | 8 | 2025 | 701 | 1.720 |
Why?
|
| Female | 60 | 2026 | 15634 | 1.680 |
Why?
|
| Adult | 43 | 2026 | 8030 | 1.640 |
Why?
|
| Gastroplasty | 4 | 2025 | 6 | 1.630 |
Why?
|
| Humans | 79 | 2026 | 28884 | 1.590 |
Why?
|
| Retrospective Studies | 26 | 2026 | 2635 | 1.590 |
Why?
|
| Wounds, Penetrating | 2 | 2026 | 31 | 1.580 |
Why?
|
| Herniorrhaphy | 3 | 2018 | 17 | 1.500 |
Why?
|
| United States | 19 | 2026 | 2225 | 1.370 |
Why?
|
| Wounds and Injuries | 3 | 2025 | 191 | 1.350 |
Why?
|
| Aged | 22 | 2026 | 5599 | 1.210 |
Why?
|
| Cholecystectomy, Laparoscopic | 4 | 2016 | 20 | 1.210 |
Why?
|
| Registries | 3 | 2020 | 397 | 1.150 |
Why?
|
| Hernia, Ventral | 2 | 2018 | 11 | 1.090 |
Why?
|
| Reoperation | 3 | 2025 | 153 | 1.070 |
Why?
|
| Surgical Procedures, Operative | 3 | 2018 | 49 | 1.050 |
Why?
|
| Colostomy | 2 | 2025 | 9 | 1.050 |
Why?
|
| Databases, Factual | 11 | 2026 | 270 | 1.050 |
Why?
|
| Quality Improvement | 6 | 2025 | 124 | 1.040 |
Why?
|
| Body Mass Index | 8 | 2025 | 412 | 1.010 |
Why?
|
| Laparotomy | 3 | 2026 | 35 | 1.000 |
Why?
|
| Length of Stay | 12 | 2026 | 245 | 0.970 |
Why?
|
| Weight Loss | 7 | 2025 | 83 | 0.960 |
Why?
|
| Duodenum | 1 | 2025 | 18 | 0.940 |
Why?
|
| Abdominal Injuries | 1 | 2026 | 35 | 0.940 |
Why?
|
| Inpatients | 1 | 2025 | 60 | 0.920 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2026 | 81 | 0.910 |
Why?
|
| Robotic Surgical Procedures | 3 | 2026 | 51 | 0.910 |
Why?
|
| Liver Cirrhosis | 1 | 2026 | 78 | 0.900 |
Why?
|
| Risk Factors | 15 | 2025 | 2127 | 0.860 |
Why?
|
| Tissue Adhesives | 2 | 2015 | 5 | 0.820 |
Why?
|
| Treatment Outcome | 16 | 2025 | 2426 | 0.810 |
Why?
|
| Elective Surgical Procedures | 3 | 2025 | 74 | 0.810 |
Why?
|
| Trauma Centers | 2 | 2025 | 125 | 0.810 |
Why?
|
| Anastomotic Leak | 4 | 2017 | 9 | 0.810 |
Why?
|
| Mammaplasty | 1 | 2022 | 12 | 0.770 |
Why?
|
| Venous Thromboembolism | 4 | 2022 | 136 | 0.760 |
Why?
|
| Injury Severity Score | 4 | 2026 | 131 | 0.750 |
Why?
|
| Sutures | 2 | 2012 | 15 | 0.720 |
Why?
|
| Cardiovascular Diseases | 4 | 2024 | 381 | 0.710 |
Why?
|
| Patient Transfer | 2 | 2018 | 43 | 0.710 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 215 | 0.670 |
Why?
|
| Heart Injuries | 1 | 2020 | 8 | 0.640 |
Why?
|
| Forecasting | 1 | 2020 | 76 | 0.620 |
Why?
|
| Aorta, Abdominal | 1 | 2019 | 15 | 0.600 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2019 | 24 | 0.600 |
Why?
|
| Hospital Mortality | 5 | 2026 | 159 | 0.590 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 481 | 0.580 |
Why?
|
| Anastomosis, Surgical | 2 | 2025 | 38 | 0.580 |
Why?
|
| Vascular Surgical Procedures | 1 | 2019 | 55 | 0.580 |
Why?
|
| Accidental Falls | 1 | 2018 | 32 | 0.550 |
Why?
|
| Models, Statistical | 1 | 2018 | 128 | 0.550 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 344 | 0.540 |
Why?
|
| Prospective Studies | 9 | 2017 | 1280 | 0.520 |
Why?
|
| Operative Time | 6 | 2016 | 41 | 0.520 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 483 | 0.510 |
Why?
|
| Hemorrhoidectomy | 1 | 2016 | 2 | 0.510 |
Why?
|
| Hemorrhoids | 1 | 2016 | 3 | 0.510 |
Why?
|
| Laser Coagulation | 1 | 2016 | 13 | 0.510 |
Why?
|
| Clinical Clerkship | 1 | 2016 | 20 | 0.500 |
Why?
|
| Pancreatitis | 1 | 2016 | 36 | 0.500 |
Why?
|
| Young Adult | 7 | 2026 | 2839 | 0.490 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2016 | 4 | 0.490 |
Why?
|
| Pain, Postoperative | 2 | 2013 | 62 | 0.480 |
Why?
|
| Program Evaluation | 1 | 2016 | 174 | 0.470 |
Why?
|
| Stress, Physiological | 1 | 2016 | 96 | 0.460 |
Why?
|
| Students, Medical | 1 | 2016 | 102 | 0.450 |
Why?
|
| Liver Diseases, Parasitic | 1 | 2014 | 3 | 0.440 |
Why?
|
| Echinococcosis | 1 | 2014 | 2 | 0.440 |
Why?
|
| Enteral Nutrition | 1 | 2014 | 23 | 0.430 |
Why?
|
| Hernia, Hiatal | 1 | 2013 | 4 | 0.420 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2014 | 41 | 0.410 |
Why?
|
| Oklahoma | 3 | 2025 | 1053 | 0.400 |
Why?
|
| Bupivacaine | 1 | 2013 | 4 | 0.400 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2013 | 6 | 0.400 |
Why?
|
| Abdominal Abscess | 1 | 2013 | 9 | 0.400 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2013 | 12 | 0.400 |
Why?
|
| Anesthetics, Local | 1 | 2013 | 12 | 0.390 |
Why?
|
| Gastroesophageal Reflux | 1 | 2013 | 84 | 0.390 |
Why?
|
| Sarcoma | 1 | 2013 | 29 | 0.390 |
Why?
|
| Acanthosis Nigricans | 1 | 2012 | 4 | 0.370 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2012 | 16 | 0.370 |
Why?
|
| Prevalence | 3 | 2025 | 518 | 0.370 |
Why?
|
| Anticoagulants | 2 | 2021 | 297 | 0.370 |
Why?
|
| Conversion to Open Surgery | 2 | 2026 | 8 | 0.350 |
Why?
|
| Postoperative Care | 3 | 2017 | 68 | 0.350 |
Why?
|
| Blood Vessels | 1 | 2011 | 58 | 0.330 |
Why?
|
| Immunosuppressive Agents | 3 | 2016 | 150 | 0.330 |
Why?
|
| Glucocorticoids | 3 | 2016 | 115 | 0.330 |
Why?
|
| Stents | 1 | 2011 | 121 | 0.330 |
Why?
|
| Adolescent | 6 | 2019 | 3197 | 0.300 |
Why?
|
| Pattern Recognition, Automated | 1 | 2009 | 32 | 0.290 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2009 | 33 | 0.290 |
Why?
|
| Artificial Intelligence | 1 | 2009 | 56 | 0.280 |
Why?
|
| Patient Safety | 3 | 2019 | 39 | 0.280 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 107 | 0.270 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 995 | 0.260 |
Why?
|
| Preoperative Care | 2 | 2025 | 81 | 0.250 |
Why?
|
| Algorithms | 1 | 2009 | 431 | 0.240 |
Why?
|
| Nutrition Surveys | 1 | 2025 | 32 | 0.240 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2017 | 18 | 0.240 |
Why?
|
| International Classification of Diseases | 1 | 2025 | 38 | 0.240 |
Why?
|
| Treatment Failure | 1 | 2025 | 73 | 0.240 |
Why?
|
| Renal Dialysis | 2 | 2016 | 53 | 0.230 |
Why?
|
| Anti-Obesity Agents | 1 | 2025 | 5 | 0.230 |
Why?
|
| Sepsis | 2 | 2020 | 86 | 0.230 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 303 | 0.220 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 2065 | 0.220 |
Why?
|
| Hospitalization | 3 | 2024 | 201 | 0.210 |
Why?
|
| Comorbidity | 3 | 2019 | 261 | 0.200 |
Why?
|
| Prognosis | 3 | 2016 | 811 | 0.200 |
Why?
|
| African Americans | 2 | 2015 | 352 | 0.200 |
Why?
|
| Splenectomy | 2 | 2015 | 44 | 0.190 |
Why?
|
| Stroke Volume | 1 | 2022 | 124 | 0.180 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 115 | 0.180 |
Why?
|
| Venous Thrombosis | 1 | 2022 | 98 | 0.180 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2019 | 71 | 0.180 |
Why?
|
| Cohort Studies | 4 | 2017 | 897 | 0.170 |
Why?
|
| Pulmonary Embolism | 1 | 2022 | 126 | 0.170 |
Why?
|
| Survival Rate | 2 | 2020 | 432 | 0.170 |
Why?
|
| Esophagectomy | 2 | 2011 | 10 | 0.170 |
Why?
|
| China | 1 | 2021 | 64 | 0.170 |
Why?
|
| Diabetic Foot | 2 | 2013 | 17 | 0.170 |
Why?
|
| Limb Salvage | 2 | 2013 | 21 | 0.170 |
Why?
|
| Incidence | 2 | 2020 | 572 | 0.170 |
Why?
|
| Esophageal Neoplasms | 2 | 2011 | 33 | 0.160 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 787 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 404 | 0.160 |
Why?
|
| Adiposity | 1 | 2021 | 94 | 0.160 |
Why?
|
| Medicine | 1 | 2019 | 22 | 0.150 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 1032 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2018 | 631 | 0.150 |
Why?
|
| Direct Service Costs | 1 | 2018 | 1 | 0.150 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 40 | 0.150 |
Why?
|
| Hypertension | 3 | 2016 | 309 | 0.150 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2016 | 68 | 0.140 |
Why?
|
| Personnel Turnover | 1 | 2018 | 11 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2020 | 739 | 0.140 |
Why?
|
| Job Satisfaction | 1 | 2018 | 24 | 0.140 |
Why?
|
| Blood Glucose | 2 | 2018 | 310 | 0.140 |
Why?
|
| Creatinine | 2 | 2015 | 59 | 0.140 |
Why?
|
| Trauma Severity Indices | 1 | 2018 | 37 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2018 | 288 | 0.140 |
Why?
|
| Patient Admission | 1 | 2018 | 30 | 0.140 |
Why?
|
| Gastric Fistula | 1 | 2017 | 1 | 0.140 |
Why?
|
| Hyperglycemia | 1 | 2018 | 78 | 0.140 |
Why?
|
| Double-Blind Method | 2 | 2016 | 422 | 0.130 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 108 | 0.130 |
Why?
|
| Physicians | 1 | 2018 | 83 | 0.130 |
Why?
|
| Hospital Costs | 1 | 2017 | 31 | 0.130 |
Why?
|
| Age Distribution | 1 | 2017 | 73 | 0.130 |
Why?
|
| Sex Distribution | 1 | 2017 | 78 | 0.130 |
Why?
|
| Actinomycosis | 1 | 2016 | 3 | 0.130 |
Why?
|
| Back Pain | 1 | 2016 | 21 | 0.130 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 51 | 0.130 |
Why?
|
| Feedback | 1 | 2016 | 33 | 0.120 |
Why?
|
| Hernia, Inguinal | 1 | 2016 | 6 | 0.120 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 63 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2017 | 72 | 0.120 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 40 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 351 | 0.120 |
Why?
|
| Spinal Fractures | 1 | 2016 | 44 | 0.120 |
Why?
|
| Internship and Residency | 1 | 2019 | 250 | 0.120 |
Why?
|
| Heart Failure | 1 | 2019 | 253 | 0.120 |
Why?
|
| Epinephrine | 1 | 2016 | 37 | 0.120 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 1002 | 0.120 |
Why?
|
| Cholecystectomy | 1 | 2016 | 16 | 0.120 |
Why?
|
| Abdomen | 1 | 2016 | 41 | 0.120 |
Why?
|
| Smoking | 2 | 2017 | 478 | 0.120 |
Why?
|
| Propensity Score | 3 | 2024 | 59 | 0.120 |
Why?
|
| Stroke | 1 | 2019 | 261 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 94 | 0.120 |
Why?
|
| Pressure | 1 | 2016 | 90 | 0.120 |
Why?
|
| Stomach | 1 | 2015 | 43 | 0.120 |
Why?
|
| Serum Albumin | 1 | 2015 | 35 | 0.120 |
Why?
|
| Hydrocortisone | 1 | 2016 | 89 | 0.120 |
Why?
|
| Steroids | 1 | 2016 | 58 | 0.120 |
Why?
|
| Florida | 1 | 2015 | 55 | 0.110 |
Why?
|
| Blood Coagulation Disorders | 1 | 2015 | 28 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2016 | 222 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 70 | 0.110 |
Why?
|
| Health Status | 1 | 2016 | 149 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 302 | 0.110 |
Why?
|
| Albendazole | 1 | 2014 | 2 | 0.110 |
Why?
|
| Anthelmintics | 1 | 2014 | 4 | 0.110 |
Why?
|
| Suction | 1 | 2014 | 10 | 0.110 |
Why?
|
| Infant, Newborn | 1 | 2018 | 916 | 0.110 |
Why?
|
| Infant | 1 | 2018 | 1025 | 0.110 |
Why?
|
| Child, Preschool | 1 | 2018 | 1173 | 0.110 |
Why?
|
| Postoperative Period | 1 | 2014 | 68 | 0.110 |
Why?
|
| Rectal Neoplasms | 1 | 2014 | 10 | 0.110 |
Why?
|
| Thyroidectomy | 1 | 2013 | 6 | 0.110 |
Why?
|
| Premedication | 1 | 2013 | 5 | 0.110 |
Why?
|
| Voice Disorders | 1 | 2013 | 3 | 0.100 |
Why?
|
| Rectal Diseases | 1 | 2013 | 10 | 0.100 |
Why?
|
| Ileostomy | 1 | 2013 | 6 | 0.100 |
Why?
|
| Colonic Diseases | 1 | 2013 | 10 | 0.100 |
Why?
|
| Thyroid Diseases | 1 | 2013 | 9 | 0.100 |
Why?
|
| Iran | 1 | 2013 | 15 | 0.100 |
Why?
|
| Dexamethasone | 1 | 2013 | 63 | 0.100 |
Why?
|
| Intensive Care Units | 1 | 2013 | 50 | 0.100 |
Why?
|
| Intraoperative Complications | 1 | 2013 | 47 | 0.100 |
Why?
|
| Child | 2 | 2018 | 2291 | 0.100 |
Why?
|
| Administration, Rectal | 1 | 2013 | 5 | 0.100 |
Why?
|
| Administration, Cutaneous | 1 | 2013 | 19 | 0.100 |
Why?
|
| Time Factors | 2 | 2014 | 1613 | 0.100 |
Why?
|
| Shivering | 1 | 2013 | 1 | 0.100 |
Why?
|
| Morphine | 1 | 2013 | 29 | 0.100 |
Why?
|
| Anesthetics | 1 | 2013 | 9 | 0.100 |
Why?
|
| Acupuncture Therapy | 1 | 2013 | 5 | 0.100 |
Why?
|
| Neoplasms | 1 | 2022 | 874 | 0.100 |
Why?
|
| Anesthesia, General | 1 | 2013 | 30 | 0.100 |
Why?
|
| Choledocholithiasis | 1 | 2012 | 1 | 0.090 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2012 | 3 | 0.090 |
Why?
|
| Amputation | 2 | 2013 | 42 | 0.090 |
Why?
|
| Pain Measurement | 1 | 2013 | 172 | 0.090 |
Why?
|
| Feeding and Eating Disorders | 1 | 2012 | 15 | 0.090 |
Why?
|
| Chronic Pain | 1 | 2013 | 62 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 379 | 0.090 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 121 | 0.090 |
Why?
|
| Sleep Wake Disorders | 1 | 2012 | 65 | 0.090 |
Why?
|
| Immunophenotyping | 1 | 2010 | 61 | 0.080 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2010 | 27 | 0.080 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2010 | 4 | 0.080 |
Why?
|
| Thyroid Neoplasms | 1 | 2010 | 39 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2010 | 292 | 0.080 |
Why?
|
| Carcinoma | 1 | 2010 | 74 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2010 | 152 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 344 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2009 | 59 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 524 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 415 | 0.060 |
Why?
|
| Tracheal Diseases | 1 | 2006 | 2 | 0.060 |
Why?
|
| Ossification, Heterotopic | 1 | 2006 | 7 | 0.060 |
Why?
|
| Cartilage Diseases | 1 | 2006 | 5 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2019 | 237 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2006 | 27 | 0.060 |
Why?
|
| Debridement | 2 | 2013 | 10 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 36 | 0.040 |
Why?
|
| Drainage | 2 | 2013 | 45 | 0.040 |
Why?
|
| Ischemia | 2 | 2013 | 83 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 97 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2018 | 7 | 0.040 |
Why?
|
| Burnout, Professional | 1 | 2018 | 21 | 0.030 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2018 | 44 | 0.030 |
Why?
|
| Contraindications, Procedure | 1 | 2017 | 1 | 0.030 |
Why?
|
| Benchmarking | 1 | 2016 | 33 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 211 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 60 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 536 | 0.030 |
Why?
|
| Surgical Stapling | 1 | 2015 | 1 | 0.030 |
Why?
|
| Suture Techniques | 1 | 2015 | 29 | 0.030 |
Why?
|
| Overweight | 1 | 2016 | 114 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2014 | 22 | 0.030 |
Why?
|
| Logistic Models | 1 | 2015 | 410 | 0.030 |
Why?
|
| Ohio | 1 | 2013 | 10 | 0.030 |
Why?
|
| Voice Quality | 1 | 2013 | 3 | 0.030 |
Why?
|
| Cause of Death | 1 | 2014 | 73 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2013 | 66 | 0.030 |
Why?
|
| Anal Canal | 1 | 2013 | 20 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 467 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2013 | 69 | 0.030 |
Why?
|
| Rectum | 1 | 2013 | 50 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 126 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 236 | 0.030 |
Why?
|
| Age Factors | 1 | 2015 | 737 | 0.030 |
Why?
|
| Heel | 1 | 2013 | 3 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 391 | 0.020 |
Why?
|
| Diabetic Neuropathies | 1 | 2013 | 16 | 0.020 |
Why?
|
| Osteomyelitis | 1 | 2013 | 14 | 0.020 |
Why?
|
| Vascular Grafting | 1 | 2013 | 11 | 0.020 |
Why?
|
| Colon | 1 | 2013 | 123 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 2013 | 24 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 480 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2013 | 66 | 0.020 |
Why?
|
| Cholangiography | 1 | 2012 | 7 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2012 | 19 | 0.020 |
Why?
|
| Wound Healing | 1 | 2013 | 126 | 0.020 |
Why?
|
| Polysomnography | 1 | 2012 | 48 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 347 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2010 | 24 | 0.020 |
Why?
|
| Receptors, Thyrotropin | 1 | 2010 | 1 | 0.020 |
Why?
|
| Laser Capture Microdissection | 1 | 2010 | 9 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2010 | 32 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2010 | 103 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 51 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 270 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2008 | 28 | 0.020 |
Why?
|
| Foot | 1 | 2008 | 23 | 0.020 |
Why?
|